During the first wave of the Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2) pandemic, we faced a massive clinical and organizational challenge having to manage critically ill patients outside the Intensive Care Unit (ICU). This was due to the significant imbalance between ICU bed availability and the number of patients presenting Acute Hypoxemic Respiratory Failure caused by SARS-CoV-2-related interstitial pneumonia. We therefore needed to perform Non-Invasive Ventilation (NIV) in non-intensive wards to assist these patients and relieve pressure on the ICUs and subsequently implemented a new organizational and clinical model. This study was aimed at evaluating its effectiveness and feasibility
The current gold-standard treatment for COVID-19-related hypoxemic respiratory failure is invasive m...
Objective: To determine the Outcome of non-invasive ventilation in patients with severe COVID-19 pne...
BACKGROUND: Non-invasive ventilation (NIV) is increasingly utilized for patients with acute respirat...
Introduction: The Coronavirus 2(SARS-CoV-2) outbreak spread rapidly in Italy and the lack of intensi...
The efficacy of non-invasive ventilation (NIV) in acute respiratory failure secondary to SARS-CoV-2 ...
Background: Noninvasive respiratory support (NIRS) has been diffusely employed outside the intensive...
RATIONALE: Treatment with non-invasive ventilation (NIV) in COVID-19 is frequent. Shortage of Intens...
Aim: Noninvasive ventilation (NIV) is known to reduce intubation in patients with acute hypoxemic re...
Rationale: Treatment with noninvasive ventilation (NIV) in coronavirus disease (COVID-19) is frequen...
The COVID-19 pandemic has seriously challenged worldwide healthcare systems and limited intensive ca...
Background: Non-invasive oxygenation strategies have a prominent role in the treatment of acute hypo...
The current gold-standard treatment for COVID-19-related hypoxemic respiratory failure is invasive m...
Objective: To determine the Outcome of non-invasive ventilation in patients with severe COVID-19 pne...
BACKGROUND: Non-invasive ventilation (NIV) is increasingly utilized for patients with acute respirat...
Introduction: The Coronavirus 2(SARS-CoV-2) outbreak spread rapidly in Italy and the lack of intensi...
The efficacy of non-invasive ventilation (NIV) in acute respiratory failure secondary to SARS-CoV-2 ...
Background: Noninvasive respiratory support (NIRS) has been diffusely employed outside the intensive...
RATIONALE: Treatment with non-invasive ventilation (NIV) in COVID-19 is frequent. Shortage of Intens...
Aim: Noninvasive ventilation (NIV) is known to reduce intubation in patients with acute hypoxemic re...
Rationale: Treatment with noninvasive ventilation (NIV) in coronavirus disease (COVID-19) is frequen...
The COVID-19 pandemic has seriously challenged worldwide healthcare systems and limited intensive ca...
Background: Non-invasive oxygenation strategies have a prominent role in the treatment of acute hypo...
The current gold-standard treatment for COVID-19-related hypoxemic respiratory failure is invasive m...
Objective: To determine the Outcome of non-invasive ventilation in patients with severe COVID-19 pne...
BACKGROUND: Non-invasive ventilation (NIV) is increasingly utilized for patients with acute respirat...